1197237-46-9 Usage
Uses
Used in Pharmaceutical Research and Drug Discovery:
1-(6-chloropyrazin-2-yl)ethanone is used as a chemical intermediate for the development of new pharmaceuticals, leveraging its unique structure and potential biological activity to contribute to the discovery of novel therapeutic agents.
Used in Organic Synthesis:
In the field of organic chemistry, 1-(6-chloropyrazin-2-yl)ethanone is used as a building block for the synthesis of other complex organic compounds, facilitating the creation of a diverse range of molecules with various applications.
Used in Medicine:
Given its potential biological activity, 1-(6-chloropyrazin-2-yl)ethanone may be employed as an active pharmaceutical ingredient or a precursor in the development of new medications, particularly if its properties align with the treatment of specific medical conditions.
Used in Agriculture:
1-(6-chloropyrazin-2-yl)ethanone could also find applications in agriculture, potentially serving as a component in the development of new agrochemicals, such as pesticides or herbicides, due to its chemical structure and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 1197237-46-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,7,2,3 and 7 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1197237-46:
(9*1)+(8*1)+(7*9)+(6*7)+(5*2)+(4*3)+(3*7)+(2*4)+(1*6)=179
179 % 10 = 9
So 1197237-46-9 is a valid CAS Registry Number.
1197237-46-9Relevant academic research and scientific papers
LYSOPHOSPHATIDIC ACID RECEPTOR 1 (LPAR1) INHIBITOR COMPOUNDS
-
Page/Page column 13; 14, (2019/03/17)
A compound of formula (I) or a pharmaceutical salt thereof, use, methods for its preparation are described.
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
-
, (2015/02/02)
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
-
, (2015/02/18)
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
